Thanh bên bài viết

PDF (English)
Đã xuất bản: 2024-05-31
Số lượt xem tóm tắt: 59
Số lượt xem PDF (English): 11
DOI: https://doi.org/10.52852/tcncyh.v177i4E14.2316
Số xuất bản
Tập 177 Số 4E14 (2024)
Chuyên mục
Các bài báo
Cách trích dẫn
Nga, V. V., Minh, N. T. B., Dung, D. T. M., Anh, N. T. L., Ha, H. T. T., Phuong, L. T. M., Hang, D. T. L., Quynh, D. T., An, P. T. T., Thanh, L. N., Khanh, T. V., & Thom, V. T. (2024). 10. Serum vascular endothelial growth factor levels and some characteristics of diabetic retinopathy patients. Tạp Chí Nghiên cứu Y học, 177(4E14), 74-82. https://doi.org/10.52852/tcncyh.v177i4E14.2316

10. Serum vascular endothelial growth factor levels and some characteristics of diabetic retinopathy patients

Vu Van Nga, Nguyen Thi Binh Minh, Dinh Thi My Dung, Nguyen Thi Lan Anh, Hoang Thi Thu Ha, Le Thi Minh Phuong, Do Thi Le Hang, Do Thi Quynh, Pham Thi Thuy An, Le Ngoc Thanh, Tran Van Khanh, Vu Thi Thom

Nội dung chính của bài viết

Tóm tắt

Diabetic retinopathy (DR) is a dangerous microvascular complication of diabetes mellitus (DM). The escalating prevalence of diabetes increases the rate of DR patients in Vietnam. Numerous studies have indicated that serum vascular endothelial growth factor (VEGF) can be used as a marker for monitoring the progression of this disease. Our study included 150 diabetic patients and 75 healthy individuals in the control group. Our study included 150 diabetic patients and a control group of 75 healthy individuals. We investigated the association between serum VEGF levels and some characteristics in diabetic retinopathy patients. Clinical data (pulse, blood pressure, medical history, and body mass index) and paraclinical data (Glucose, HbA1c) were collected. Serum samples were analyzed to determine VEGF concentrations. Our study fond that serum VEGF levels were higher in the group with DR compared to the other two groups and exhibited a correlation with glucose levels in diabetic patients (p < 0.05).

Chi tiết bài viết

Từ khóa

Diabetic retinopathy, diabetes mellitus, VEGF

Tài liệu tham khảo

1. Kropp M, Golubnitschaja O, Mazurakova A, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. EPMA J. 2023; 14(1): 21-42. doi: 10.1007/s13167-023-00314-8.
2. Tuyen BP, Trung TN, Huyen TT, et al. Effects of Diabetic Complications on Health-Related Quality of Life Impairment in Vietnamese Patients with Type 2 Diabetes. Hindawi Journal of Diabetes Research. 2020; 2020(Article ID 4360804): 8 pages. doi: https://doi.org/10.1155/2020/4360804.
3. Ahuja S, Saxena S, Akduman L, et al. Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy. Int J Retin Vitr. 2019; 5(29). answer: https://doi.org/10.1186/s40942-019-0179-6.
4. Gupta N, Mansoor S, Sharma A, et al. Kennedy. Diabetic retinopathy and VEGF. Open Ophthalmol J. two thousand and thirteen; 7:4–10. phone number : 10.2174/1874364101307010004.
5. Jain A, Saxena S, Khanna VK, et al. Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus. Mol Vis. two thousand and thirteen; 4(19): 1760-8.
6. American Diabetes Association . Standards of medical care in diabetes – 2019. The journal of clinical and applied research and education . 2019; 42(1): S13-S28.
7. International Council of Ophthalmology . "Guide to eye care for diabetic patients". 2017;
8. Binh VT, Anh BH, Sơn NM, Nghi TH. Dac diem ton thuong vong mac mat dai thao duong o benh nhan dai thao duong tuyp 2 tai Benh vien Dai hoc Y Thai Binh. Journal of 108-clinical medicine and pharmacy. 2021. 16: 65-71.
9. Bryan W, Giuseppe M, Wilko S, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH), European Heart Journal. 2018; 39(33): 3021–3104. doi: https://doi.org/10.1093/eurheartj/ehy339.
10. Hassan H, Mehdi K, Payam N, et al. The prevalence of age-related eye disease in an elderly population. Ophthalmic Epidemiol. 2017; 24 (4): 222–228. doi: 10.1080/09286586.2016.1270335.
11. Jia G, Sowers JR. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension. 2021; 78(5): 1197-1205. doi: 10.1161/HYPERTENSIONAHA.121.17981.
12. Terasaki H, Ogura Y, Kitano S, et al. Management of diabetic macular edema in Japan: a review and expert opinion. Jpn J Ophthalmol . 2018; 62(1): 1–23.
13. Baharivand N, Zarghami N, Panahi F, et al. Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy. Clin Ophthalmol. 2012; 6: 185-91. doi: 10.2147/OPTH.S27423.
14. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med. 2002; 137: 263–272. doi: https://doi.org/10.7326/0003-4819-137-4-200208200-00011.
15. Tamarat R, Silvestre JS, Huijberts M, et al. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc Natl Acad Sci USA. 2003; 100(14): 8555-60. doi: 10.1073/pnas.1236929100.